Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer

Chemoimmunotherapy has been approved as standard treatment for triple-negative breast cancer (TNBC), but the clinical outcomes remain unsatisfied. Abnormal epigenetic regulation is associated with acquired drug resistance and T cell exhaustion, which is a critical factor for the poor response to che...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Tong, Sang, Xiao, Huang, Xinyan, Gu, Panpan, Liu, Jie, Liu, Yongjun, Zhang, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548052/
https://www.ncbi.nlm.nih.gov/pubmed/37799382
http://dx.doi.org/10.1016/j.apsb.2022.11.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548052/
https://www.ncbi.nlm.nih.gov/pubmed/37799382
http://dx.doi.org/10.1016/j.apsb.2022.11.018

Ejemplares similares